Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- Check2 days agoChange DetectedAdded a new citation (Ostrominski et al.) and updated the page to v3.0.2; the v3.0.1 revision label was removed and the Back to Top element was deleted.SummaryDifference0.5%
- Check9 days agoChange DetectedThe page has been updated to include a new article on heart failure biomarkers and has removed a previous article on finerenone and frailty in heart failure, reflecting the latest research developments.SummaryDifference2%
- Check16 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as detailed information about the FINEARTS-HF study, including its results and related publications. Notably, the study's focus has shifted to evaluating the efficacy and safety of Finerenone in heart failure patients.SummaryDifference100%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.3%
Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.